secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tenon Medical, Inc. (TNON)
CIK:        0001560293
Form:       8-K
Filed at:   2024-07-25T23:59:59+00:00
Accession:  0001013762-24-001130
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Tenon Medical shareholders approve director elections, equity plan amendment, and Series B terms at 2024 annual meeting
--------------------------------------------------------------------------------

- All seven director nominees elected with majority support; broker non-votes ~1.2M shares.
- Shareholders approved Series B Preferred Stock terms and warrant issuance; vote 2,391,579 for, 45,130 against.
- 2022 Equity Incentive Plan amended to add 1,100,000 shares; approved 2,318,386 for, 117,137 against.
- Haskell & White LLP ratified as independent auditor for FY2024; 3,609,093 for, 11,604 against.
- Adjournment proposal approved to solicit additional proxies if needed; 2,720,153 for.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1560293/000101376224001130/0001013762-24-001130-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1560293/000101376224001130/ea0209964-8k_tenon.htm
  HTML page:      https://secwatch.observer/filing/0001013762-24-001130

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer